{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:29:22Z","timestamp":1789763362070,"version":"4.0.1"},"reference-count":29,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Background: Gentamicin is a broad-spectrum aminoglycoside antibiotic produced by Micromonospora purpurea bacteria, effective against Gram-negative bacterial infections. Major fractions of the gentamicin complex (C1, C1a, C2, C2a) possess weak antifungal activity and one of the minor components (A, A1\u2013A4, B, B1, X), gentamicin B1 was found to be a strong antifungal agent. Methods: This work uses in vitro and in vivo dilution methods to compare the antifusarial, antiaspergillic and anticryptococcal effects of gentamicin derivatives and structurally-related congeners. Results: The in vitro antifusarial activity of gentamicin B1 (minimum inhibitory concentration (MIC) 0.4 \u03bcg\/mL) and structurally-related compounds (MIC 0.8\u201312.5 \u03bcg\/mL) suggests that the purpuroseamine ring substituents are responsible for the specific antimycotic effect. The functional groups of the garoseamine and 2-deoxystreptamine rings of gentamicin derivatives are identical in gentamicin compounds and are unlikely to exert a significant antifungal effect. Among soil dermatophytes, Microsporum gypseum was more susceptible to gentamicin B1 (MIC 3.1 \u00b5g\/mL) than Trichophyton gypseum (MIC 25 \u00b5g\/mL). The in vitro antifungal effect of gentamicin B1 against plant pathogenic fungi was comparable to primary antifungal agents. Conclusion: Gentamicin is already in medical use. In vitro and preclinical in vivo synergisms of gentamicin B1 with amphotericin B suggest immediate clinical trials starting with subtoxic doses.<\/jats:p>","DOI":"10.3390\/molecules25102401","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T10:18:18Z","timestamp":1590142698000},"page":"2401","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Antifungal Activity of Gentamicin B1 against Systemic Plant Mycoses"],"prefix":"10.3390","volume":"25","author":[{"given":"Gaspar","family":"Banfalvi","sequence":"first","affiliation":[{"name":"Department of Molecular Biotechnology and Microbiology, University of Debrecen, 4010 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,5,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1055\/s-0035-1562897","article-title":"Fusariosis","volume":"36","author":"Nucci","year":"2015","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/QCO.0b013e328348b159","article-title":"Immune responses against Aspergillusfumigatus: What have we learned?","volume":"24","author":"Cramer","year":"2011","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/thx.38.8.579","article-title":"What happens to patients with pulmonary aspergilloma? Analysis of 23 cases","volume":"38","author":"Rafferty","year":"1983","journal-title":"Thorax"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/13693780400020113","article-title":"Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: Interim results of a prospective multicenter surveillance program","volume":"43","author":"Morgan","year":"2005","journal-title":"Med. Mycol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"10353","DOI":"10.1007\/s00253-018-9407-5","article-title":"Retrospective evaluation of in vitro effect of gentamicin B1 against Fusarium species","volume":"102","author":"Banfalvi","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1055\/s-0035-1562923","article-title":"Pulmonary and invasive fungal infections","volume":"36","author":"Kaufmann","year":"2015","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/mmy\/myt028","article-title":"Development and validation of benomyl birdseed agar for the isolation of Cryptococcus neoformans and Cryptococcus gattii from environmental samples","volume":"52","author":"Pham","year":"2014","journal-title":"Med. Mycol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1039\/C4MD00078A","article-title":"Antifungal amphiphilic aminoglycosides","volume":"5","author":"Chang","year":"2014","journal-title":"MedChemComm"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"9124","DOI":"10.1021\/acs.jmedchem.5b01375","article-title":"Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles","volume":"58","author":"Fosso","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/mmy\/myv016","article-title":"Inhibitory effects of antimicrobial agents againstFusariumspecies","volume":"53","author":"Kawakami","year":"2015","journal-title":"Med. Mycol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.3390\/toxins6113157","article-title":"Screening a strain of Aspergillusniger and optimization of fermentation conditions for degradation of aflatoxin B1","volume":"6","author":"Zhang","year":"2014","journal-title":"Toxins"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.chemosphere.2014.04.060","article-title":"Comparative study of toxicity of azo dye Procion Red MX-5B following biosorption and biodegradation treatments with the fungi Aspergillusniger and Aspergillusterreus","volume":"112","author":"Almeida","year":"2014","journal-title":"Chemosphere"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"35856","DOI":"10.1038\/srep35856","article-title":"Gentamicin removal in submerged fermentation using the novel fungal strain Aspergillusterreus FZC3","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/15476286.2017.1285480","article-title":"Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells","volume":"14","author":"Bidou","year":"2017","journal-title":"RNA Boil."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6583","DOI":"10.1093\/nar\/gkw638","article-title":"Novel small molecules potentiate premature termination codon readthrough by aminoglycosides","volume":"44","author":"Balgi","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1073\/pnas.1620982114","article-title":"Gentamicin B1 is a minor gentamicin component with major nonsense mutation suppression activity","volume":"114","author":"Niesser","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","unstructured":"Howard, D.H. (2003). Aspergillus, Fusarium, Sporothrix, Piedraia, and their relatives. Pathogenic Fungi in Humans and Animals, Marcel Dekker, Inc."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3201\/eid0401.980109","article-title":"What makes Cryptococcus neoformans a pathogen?","volume":"4","author":"Buchanan","year":"1998","journal-title":"Emerg. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.2.1.1","article-title":"Reversal by calcium ion of the growth inhibition of Debaromycesnicotianae caused by antifungal polyene antibiotics","volume":"2","author":"Berdicevsky","year":"1972","journal-title":"Antimicrobial. Agents Chemother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1128\/AAC.1.6.466","article-title":"Antagonistic effect of calcium in serum on the activ.ity of tobramycin against Pseudomonas","volume":"1","author":"Davis","year":"1972","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_21","first-page":"1326","article-title":"Antagonism of neomycin by heparin. Further observations on the anaphylactoid activity of neomycin","volume":"23","author":"Raab","year":"1973","journal-title":"Arzneimittelforschung"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1039\/C8MD00155C","article-title":"Antifungal amphiphilickanamycins: New life for an old drug","volume":"9","author":"Subedi","year":"2018","journal-title":"Med. Chem. Comm."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Subedi, Y.P., Pandey, U., Alfindee, M.N., Montgomery, H., Roberts, P., Wight, J., Nichols, G., Grilley, M., Takemoto, J.Y., and Chang, C.\u2013W.T. (2019). Scalable and cost-effective tosylation-mediated synthesis of antifungal and fungal diagnostic 6\u2033-modified amphiphilickanamycins. Eur. J. Med. Chem., 182.","DOI":"10.1016\/j.ejmech.2019.111639"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Alfindee, M.N., Subedi, Y.P., Grilley, M.M., Takemoto, J.Y., and Chang, C.-W.T. (2019). Antifungal activities of 4\u2032\u2019, 6\u2032\u2019-disubstituted amphiphilic kanamycins. Molecules, 24.","DOI":"10.3390\/molecules24101882"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/ja.2010.110","article-title":"Antibacterial to antifungal conversion of neamine aminoglycosides through alkyl modification. Strategy for reviving old drugs into agrofungicides","volume":"63","author":"Chang","year":"2010","journal-title":"J. Antibiot."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1128\/AAC.43.4.727","article-title":"Aminoglycosides: Activity and Resistance","volume":"43","author":"Glupczynski","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1021\/jm00340a034","article-title":"Gentamicin,1a New Antibiotic Complex from Micromonospora","volume":"6","author":"Weinstein","year":"1963","journal-title":"J. Med. Chem."},{"key":"ref_28","unstructured":"Gad\u00f3, I., B\u00e9rdy, J., Koczka, I., Horv\u00e1th, I., J\u00e1ray, M., and Zlatos, G. (1973). Gentamicin Antibiotics. (Hungarian Patent1975)."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"945","DOI":"10.7164\/antibiotics.30.945","article-title":"Metabolites of gentamicin-producing Micromonospora species I. Isolation and identification of metabolites","volume":"30","author":"Pauncz","year":"1977","journal-title":"J. Antibiot."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/10\/2401\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:31:16Z","timestamp":1760175076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/10\/2401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,21]]},"references-count":29,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,5]]}},"alternative-id":["molecules25102401"],"URL":"https:\/\/doi.org\/10.3390\/molecules25102401","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,21]]}}}